Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
Identifieur interne : 000714 ( 2020/Extraction ); précédent : 000713; suivant : 000715Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
Auteurs : Azar Hadadi [Iran] ; Masoud Mortezazadeh [Iran] ; Kasra Kolahdouzan [Iran] ; Golbarg Alavian [Iran]Source :
- Journal of medical virology [ 1096-9071 ] ; 2020.
Abstract
An 80-year-old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever and critically low O2 saturation and definitive chest CT scan findings in favor of COVID-19 and positive PCR results in 48 h. He received antiviral treatment plus recombinant human Erythropoietin(rhEPO) due to his severe anemia. After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level. We concluded that rhEPO could attenuate respiratory distress syndrome and confront the SARS-CoV-2 virus through multiple mechanisms including cytokine modulation, anti-apoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus. This article is protected by copyright. All rights reserved.
DOI: 10.1002/jmv.25839
PubMed: 32270515
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000267
- to stream PubMed, to step Curation: 000267
- to stream PubMed, to step Checkpoint: 000558
- to stream Ncbi, to step Merge: 003842
- to stream Ncbi, to step Curation: 003842
- to stream Ncbi, to step Checkpoint: 003842
- to stream Main, to step Merge: 000714
- to stream Main, to step Curation: 000714
- to stream Main, to step Exploration: 000714
Links to Exploration step
pubmed:32270515Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?</title>
<author><name sortKey="Hadadi, Azar" sort="Hadadi, Azar" uniqKey="Hadadi A" first="Azar" last="Hadadi">Azar Hadadi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
<wicri:noRegion>Tehran</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mortezazadeh, Masoud" sort="Mortezazadeh, Masoud" uniqKey="Mortezazadeh M" first="Masoud" last="Mortezazadeh">Masoud Mortezazadeh</name>
<affiliation wicri:level="1"><nlm:affiliation>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
<wicri:noRegion>Tehran</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kolahdouzan, Kasra" sort="Kolahdouzan, Kasra" uniqKey="Kolahdouzan K" first="Kasra" last="Kolahdouzan">Kasra Kolahdouzan</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
<wicri:noRegion>Tehran</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Alavian, Golbarg" sort="Alavian, Golbarg" uniqKey="Alavian G" first="Golbarg" last="Alavian">Golbarg Alavian</name>
<affiliation wicri:level="1"><nlm:affiliation>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
<wicri:noRegion>Tehran</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32270515</idno>
<idno type="pmid">32270515</idno>
<idno type="doi">10.1002/jmv.25839</idno>
<idno type="wicri:Area/PubMed/Corpus">000267</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000267</idno>
<idno type="wicri:Area/PubMed/Curation">000267</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000267</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000558</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000558</idno>
<idno type="wicri:Area/Ncbi/Merge">003842</idno>
<idno type="wicri:Area/Ncbi/Curation">003842</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003842</idno>
<idno type="wicri:Area/Main/Merge">000714</idno>
<idno type="wicri:Area/Main/Curation">000714</idno>
<idno type="wicri:Area/Main/Exploration">000714</idno>
<idno type="wicri:Area/2020/Extraction">000714</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?</title>
<author><name sortKey="Hadadi, Azar" sort="Hadadi, Azar" uniqKey="Hadadi A" first="Azar" last="Hadadi">Azar Hadadi</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Infectious Diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
<wicri:noRegion>Tehran</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mortezazadeh, Masoud" sort="Mortezazadeh, Masoud" uniqKey="Mortezazadeh M" first="Masoud" last="Mortezazadeh">Masoud Mortezazadeh</name>
<affiliation wicri:level="1"><nlm:affiliation>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
<wicri:noRegion>Tehran</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kolahdouzan, Kasra" sort="Kolahdouzan, Kasra" uniqKey="Kolahdouzan K" first="Kasra" last="Kolahdouzan">Kasra Kolahdouzan</name>
<affiliation wicri:level="1"><nlm:affiliation>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Cancer Institute, Radiation Oncology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
<wicri:noRegion>Tehran</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Alavian, Golbarg" sort="Alavian, Golbarg" uniqKey="Alavian G" first="Golbarg" last="Alavian">Golbarg Alavian</name>
<affiliation wicri:level="1"><nlm:affiliation>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea>
<wicri:noRegion>Tehran</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of medical virology</title>
<idno type="eISSN">1096-9071</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">An 80-year-old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever and critically low O2 saturation and definitive chest CT scan findings in favor of COVID-19 and positive PCR results in 48 h. He received antiviral treatment plus recombinant human Erythropoietin(rhEPO) due to his severe anemia. After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level. We concluded that rhEPO could attenuate respiratory distress syndrome and confront the SARS-CoV-2 virus through multiple mechanisms including cytokine modulation, anti-apoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus. This article is protected by copyright. All rights reserved.</div>
</front>
</TEI>
<affiliations><list><country><li>Iran</li>
</country>
</list>
<tree><country name="Iran"><noRegion><name sortKey="Hadadi, Azar" sort="Hadadi, Azar" uniqKey="Hadadi A" first="Azar" last="Hadadi">Azar Hadadi</name>
</noRegion>
<name sortKey="Alavian, Golbarg" sort="Alavian, Golbarg" uniqKey="Alavian G" first="Golbarg" last="Alavian">Golbarg Alavian</name>
<name sortKey="Kolahdouzan, Kasra" sort="Kolahdouzan, Kasra" uniqKey="Kolahdouzan K" first="Kasra" last="Kolahdouzan">Kasra Kolahdouzan</name>
<name sortKey="Mortezazadeh, Masoud" sort="Mortezazadeh, Masoud" uniqKey="Mortezazadeh M" first="Masoud" last="Mortezazadeh">Masoud Mortezazadeh</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Extraction
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000714 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Extraction/biblio.hfd -nk 000714 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= 2020 |étape= Extraction |type= RBID |clé= pubmed:32270515 |texte= Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Extraction/RBID.i -Sk "pubmed:32270515" \ | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Extraction/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |